Replies to post #147418 on Biotech Values

[iwfal]

ONCY

How much data the company gives to us is a different story, I am afraid!! Often the provided information is limited and critical raw data is considered to be "secret". I am pretty sure that the defined survival numbers from Part 1 are partly to be used to define enrolment numbers for Part 2. This is the way I understand it, anyways.

If the protocol really is as complex as you wrote up previously and the company isn't completely tranarent it is a ripe opportunity for abusing shareholders. ONCY in particular has a
long history of questionable underpowered single arm trials without an obvious result so I would be dubious of anything but complete transparency.

PS Where did you come by your understanding of the trial protocol as per your previous post?